The economic burden of atherothrombosis in Greece: Results from the THESIS study

European Journal of Health Economics

Volumn 14, Issue 4, 2013, Pages 655-665

  Maniadakis, Nikos ^a   Kourlaba, Georgia ^a   Cokkinos, Dennis V ^b   Angeli, Aggeliki ^c   Kyriopoulos, John ^a  

^a NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^b Academy of Athens Biomedical Research Foundation   (Greece)

^c Sanofi Aventis Greece   (Greece)

Author keywords

Atherothrombotic disease; Burden of disease; Cardiovascular disease; Cost of illness study; Direct costs; Indirect costs

Indexed keywords

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DRUG COST; FEMALE; FOLLOW UP; GREECE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PRODUCTIVITY; THROMBOSIS;

ATHEROSCLEROSIS; COST OF ILLNESS; FEMALE; GREECE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; THROMBOSIS;

EID: 84879928041     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-012-0412-9     Document Type: Article

References (30)

1. Lloyd-Jones, D.; Adams, R.J.; Brown, T.M.; Carnethon, M.; Dai, S.; De Simone, G.; Ferguson, T.B.; Ford, E.; Furie, K.; Gillespie, C.; Go, A.; Greenlund, K.; Haase, N.; Hailpern, S.; Ho, P.M.; Howard, V.; Kissela, B.; Kittner, S.; Lackland, D.; Lisabeth, L.; Marelli, A.; McDermott, M.M.; Meigs, J.; Mozaffarian, D.; Mussolino, M.; Nichol, G.; Roger, V.L.; Rosamond, W.; Sacco, R.; Sorlie, P.; Thom, T.; Wasserthiel-Smoller, S.; Wong, N.D.; Wylie-Rosett, J.: Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 121(7), e46-e215 (2010). doi: 10.1161/CIRCULATIONAHA.109.192667
2. Rayner, M.; Allender, S.; Scarborough, P.: Cardiovascular disease in Europe. Eur. J. Cardiovasc. Prev. Rehabil. 16(Suppl 2), S43-S47 (2009)
3. World Health Organization: Cardiovascular diseases (CVD). www.who.int/mediacentre/factsheets/fs317/en/print.html. Accessed Accessed October 8, 2010
4. Tarricone, R.: Cost-of-illness analysis. What room in health economics? Health Policy 77, 51-63 (2006)
5. Nichols, G.A.; Bell, T.J.; Pedula, K.L.; O'Keeffe-Rosetti, M.: Medical care costs among patients with established cardiovascular disease. Am. J. Manag. Care 16(3), e86-e93 (2010). 12584 [pii]
6. Doan, Q.V.; Gleeson, M.; Kim, J.; Borker, R.; Griffiths, R.; Dubois, R.W.: Economic burden of cardiovascular events and fractures among patients with end-stage renal disease. Curr. Med. Res. Opin. 23(7), 1561-1569 (2007)
7. Liu, J.L.; Maniadakis, N.; Gray, A.; Rayner, M.: The economic burden of coronary heart disease in the UK. Heart 88(6), 597-603 (2002)
8. Etemad, L.R.; McCollam, P.L.: Total first-year costs of acute coronary syndrome in a managed care setting. J. Manag. Care Pharm. 11(4), 355-357 (2005)
9. Turpie, A.G.: Burden of disease: medical and economic impact of acute coronary syndromes. Am. J. Manag. Care 12(16 Suppl), S430-S434 (2006)
10. Taylor, M.J.; Scuffham, P.A.; McCollam, P.L.; Newby, D.E.: Acute coronary syndromes in Europe: 1-year costs and outcomes. Curr. Med. Res. Opin. 23(3), 495-503 (2007)
11. Menzin, J.; Wygant, G.; Hauch, O.; Jackel, J.; Friedman, M.: One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database. Curr. Med. Res. Opin. 24(2), 461-468 (2008)
12. Duh, M.S.; Fulcher, N.M.; White, L.A.; Jayawant, S.S.; Ramamurthy, P.; Moyneur, E.; Ong, S.H.: Costs associated with cardiovascular events in patients with hypertension in US managed care settings. J. Am. Soc. Hypertens. 3(6), 403-415 (2009)
13. Yang, L.; Wu, M.; Cui, B.; Xu, J.: Economic burden of cardiovascular diseases in China. Exp. Rev. Pharmacoecon. Outcomes Res. 8(4), 349-356 (2008)
14. Gaziano, T.A.: Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa. Heart 94(2), 140-144 (2008)
15. Saka, O.; McGuire, A.; Wolfe, C.: Cost of stroke in the United Kingdom. Age Ageing 38(1), 27-32 (2009)
16. Gerzeli, S.; Tarricone, R.; Zolo, P.; Colangelo, I.; Busca, M.R.; Gandolfo, C.: The economic burden of stroke in Italy. The EcLIPSE study: economic longitudinal incidence-based project for stroke evaluation. Neurol. Sci. 26(2), 72-80 (2005)
17. Youman, P.; Wilson, K.; Harraf, F.; Kalra, L.: The economic burden of stroke in the United Kingdom. Pharmacoeconomics 21(Suppl 1), 43-50 (2003)
18. Leal, J.; Luengo-Fernandez, R.; Gray, A.; Petersen, S.; Rayner, M.: Economic burden of cardiovascular diseases in the enlarged European Union. Eur. Heart J. 27(13), 1610-1619 (2006)
19. Migliaccio-Walle, K.; Caro, J.J.; Ishak, K.J.; O'Brien, J.A.: Costs and medical care consequences associated with the diagnosis of peripheral arterial disease. Pharmacoeconomics 23, 733-742 (2004)
20. Kontodimopoulos, N.; Pappa, E.; Niakas, D.; Yfantopoulos, J.; Dimitrakaki, C.; Tountas, Y.: Validity of the EuroQoL (EQ-5D) instrument in a Greek general population. Value Health 11(7), 1162-1169 (2008)
21. Greek Ministry of Economy, Competitiveness and Shipping: Drug price bulletin. http://www.gge.gr/37/index.asp. Accessed at 11 January 2011
22. Maniadakis, N.; Kourlaba, G.; Fragoulakis, V.: Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece: a telephone survey. BMC Cardiovasc. Disord. 11, 16 (2011). doi: 10.1186/1471-2261-11-16
23. Barber, J.A.; Thompson, S.G.: Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat. Med. 19(23), 3219-3236 (2000)
24. Moran, J.L.; Solomon, P.J.; Peisach, A.R.; Martin, J.: New models for old questions: generalized linear models for cost prediction. J. Eval. Clin. Pract. 13(3), 381-389 (2007). doi: 10.1111/j.1365-2753.2006.00711.x
25. Mahoney, E.M.; Wang, K.; Cohen, D.J.; Hirsch, A.T.; Alberts, M.J.; Eagle, K.; Mosse, F.; Jackson, J.D.; Steg, P.G.; Bhatt, D.L.: REACH Registry Investigators: One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ. Cardiovasc. Qual. Outcomes 1(1), 38-45 (2008)
26. Levy, E.; Gabriel, S.; Dinet, J.: The comparative medical costs of atherothrombotic disease in European countries. Pharmacoeconomics 21(9), 651-659 (2003)
27. Vlayen, J.; De Backer, G.; Peers, J.; Moldenaers, I.; Debruyne, H.; Simoens, S.: Atherosclerotic cardiovascular diseases in Belgium: a cost-of-illness analysis. Cardiovasc. Drugs Ther. 22(6), 487-494 (2008)
28. Boden, W.E.; O'Rourke, R.A.; Teo, K.K.; Hartigan, P.M.; Maron, D.J.; Kostuk, W.J.; Knudtson, M.; Dada, M.; Casperson, P.; Harris, C.L.; Chaitman, B.R.; Shaw, L.; Gosselin, G.; Nawaz, S.; Title, L.M.; Gau, G.; Blaustein, A.S.; Booth, D.C.; Bates, E.R.; Spertus, J.A.; Berman, D.S.; Mancini, G.B.; Weintraub, W.S.: Optimal medical therapy with or without PCI for stable coronary disease. N. Engl. J. Med. 356(15), 1503-1516 (2007). doi: 10.1056/NEJMoa070829
29. Ademi, Z.; Liew, D.; Hollingsworth, B.; Wolfe, R.; Steg, G.P.; Bhatt, D.L.; Reid, C.M.: The economic implications of treating atherothrombotic disease in Australia, from the government perspective. Clin. Ther. 32(1), 119-132; discussion 106-117 (2010). doi: 10.1016/j.clinthera.2010.01.009
30. Allender, S.; Scarborough, P.; Peto, V.; Rayner, M.; Leal, J.; Luengo-Fernandez, R.; Gray, A.: European cardiovascular disease statistics, 2008th edn. European Heart Network, Brussels (2008)